Response to letter regarding article, "hormone therapy and venous thromboembolism among postmenopausal women: Impact of the route of estrogen administration and progestogens: Ehe Esther study" [2]

Circulation

Volumn 116, Issue 13, 2007, Pages

  Canonico, Marianne ^a   Oger, Emmanuel ^a   Plu Bureau, Geneviève ^a   Scarabin, Pierre Yves ^a   Conard, Jacqueline ^b   Meyer, Guy ^b   Lévesque, Hervé ^c   Trillot, Nathalie ^d   Barrellier, Marie Thérèse ^e   Wahl, Denis ^f   Emmerich, Joseph ^b  

^a INSERM   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ DE ROUEN   (France)

^d Center Hospitalier et Universitaire   (France)

^e CHU CÔTE DE NACRE   (France)

^f CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; PREGNANE DERIVATIVE; PROGESTERONE;

HORMONAL THERAPY; HUMAN; LETTER; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR; THROMBOGENICITY; VENOUS THROMBOEMBOLISM;

EID: 34748854272     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.107.715607     Document Type: Letter

References (2)

1. Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, Trillot N, Barrellier MT, Wahl D, Emmerich J, Scarabin PY; Estrogen and Thromboembolism Risk (ESTHER) Study Group. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115:840-845.
2. Conard J, Denis C, Basdevant A, Guyenne TT, Thomas JL, Degrelle H, Ochsenbein E. Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol. Fertil Steril. 1995;64:957-962.